CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipients

MV Yanik, ME Seifert, JE Locke… - Pediatric …, 2019 - Wiley Online Library
Background Optimal management of immunosuppression in kidney transplantation requires
a delicate balance of efficacy and toxicity. Tacrolimus (TAC) dose requirements are …
被引用次数：12 相关文章
[HTML] nih.gov

[HTML][HTML] CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipients

MV Yanik, ME Seifert, JE Locke… - Pediatric …, 2019 - ncbi.nlm.nih.gov
Background: Optimal management of immunosuppression in kidney transplantation requires
a delicate balance of efficacy and toxicity. Tacrolimus (TAC) dose requirements are …

CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipients

MV Yanik, ME Seifert, JE Locke… - Pediatric …, 2019 - experts.nebraska.edu
Background: Optimal management of immunosuppression in kidney transplantation requires
a delicate balance of efficacy and toxicity. Tacrolimus (TAC) dose requirements are …

CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipients.

MV Yanik, ME Seifert, JE Locke… - Pediatric …, 2019 - europepmc.org
Background Optimal management of immunosuppression in kidney transplantation requires
a delicate balance of efficacy and toxicity. Tacrolimus (TAC) dose requirements are …

CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipients

MV Yanik, ME Seifert, JE Locke… - Pediatric …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Optimal management of immunosuppression in kidney transplantation requires
a delicate balance of efficacy and toxicity. Tacrolimus (TAC) dose requirements are …

CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipients.

MV Yanik, ME Seifert, JE Locke… - Pediatric …, 2019 - search.ebscohost.com
Background: Optimal management of immunosuppression in kidney transplantation requires
a delicate balance of efficacy and toxicity. Tacrolimus (TAC) dose requirements are …